Asia Pacific Aesthetic Medicine Market size to exceed $7.5 Bn by 2027, says Graphical Research

Graphical Research
Graphical Research

Major aesthetic medicine market players in Asia Pacific region include Allergan, Galderma, Shanghai Haohai Biological Technology Co., Ltd., Humedix, and Cynosure.

Pune, India, Sept. 15, 2022 (GLOBE NEWSWIRE) --

As per a recent industry report put forward by Graphical Research, the Asia Pacific aesthetic medicine market is forecast to register its name in the million-dollar fraternity down the line of seven years, by exceeding a revenue of USD 7.5 billion by 2027.


The market growth is due to increasing adoption of minimally invasive surgeries and advanced cosmetic procedures. Developments in both surgical and non-surgical aesthetic procedures will remain a catalyst amidst high costs and a lack of skilled manpower.

Access sample pages of the report, “Asia Pacific Aesthetic Medicine Market Forecasts 2027” in detail along with the table of contents (ToC) @

https://www.graphicalresearch.com/request/1795/sample

Some of the most popular aesthetic procedures, including lasers for hair removal, Botox, pigmentation reduction, skin resurfacing, and hyaluronic acid fillers are expected to be sought-after across the emerging economies. The number of aesthetic procedures declined during the onslaught of coronavirus, hampering the supply chain across the region.

Meanwhile, rising cases of obesity and the tendency to hide the signs of aging will continue to foster industry growth. According to a study, Asia Pacific aesthetic medicine market size would surpass USD 7.5 billion by 2027.

  1. Surgical procedures to be sought-after

A dramatic rise in the number of facial aesthetic surgeries will encourage leading companies to expand their penetration across untapped areas. Besides, rampant breast cancer in Australia, China and India will usher the need for advanced procedures. Prominently, women have shown an increased preference for breast augmentation surgery. Asia Pacific aesthetic medicine market share from surgical procedures will observe a robust growth rate of around 7.9% up to 2027.

  1. Significance of energy-based aesthetic medicine

Industry participants are expected to exhibit a preference for technologies, including cryolipolysis and radiofrequency for fat reduction, skin rejuvenation with minimal blood loss and invasion. Specifically, heightened awareness about light-based, laser-based and ultrasound aesthetic devices will bolster the growth potential. APAC industry value from energy-based aesthetic medicine could witness a healthy growth rate of more than 11.3% through 2027.

  1. Females exhibit high preference for aesthetic medicine

A notable uptick in the number of breast augmentations, as well as the surge in the demand for facial aesthetic procedures, will augur well for the industry size expansion. Skin rejuvenation and injectables are likely to be preferred across the Pacific region. Female segment contributed around 75.4% share towards APAC aesthetic medicine market in 2020 and will witness an upward trend over 2021-2027.